Expert Discusses Considerations for Inpatient Use of Diabetes Technology
Pharmacy Times
DECEMBER 5, 2022
Michelle Condren, PharmD, AE-C, BCPPS, CDCES, FPPA, discussed pharmacists' roles in inpatient diabetes management.
Pharmacy Times
DECEMBER 5, 2022
Michelle Condren, PharmD, AE-C, BCPPS, CDCES, FPPA, discussed pharmacists' roles in inpatient diabetes management.
Pharmacy Joe
MAY 14, 2023
In this episode, I’ll discuss how to predict failure of insulin transition in critically ill patients with diabetic ketoacidosis. If you like this post, check out my book – A Pharma cist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ALiEM - Pharm Pearls
OCTOBER 30, 2024
Inpatient wound care teams provided long-term support and a nutrition consult ordered protein, micronutrient, and vitamin supplementation. Clonidine is often added back to their regimens inpatient as their vital signs tolerate.
Pharmacy Joe
DECEMBER 30, 2020
Episode 570: Euglycemic Diabetic Ketoacidosis After Stopping Canagliflozin Subscribe on iTunes , Android , or Stitcher Shout-out to “Pharmacy Ashley” for inspiring this episode! In this episode, I’ll discuss the possibility of euglycemic DKA occurring after stopping canagliflozin.
PharmD Live
FEBRUARY 26, 2025
For conditions like HIV prevention and diabetes management, non-adherence increases hospitalization risks, elevating long-term treatment costs. Lowering Hospitalization Risks : Adherence-focused interventions prevent costly ER visits and inpatient stays.
vizient
MARCH 7, 2024
Medical Device Tech Watch: With the migration of musculoskeletal procedures to the outpatient setting, inpatient providers can mitigate the volume loss with targeted ambulatory strategies. This edition of Tech Watch also surveys treatment options for diabetic neuropathy.
pharmaphorum
FEBRUARY 28, 2022
The analysis by IQVIA and pharma company Chiesi looked at the per patient, per year (PPPY) direct, indirect and mortality-related costs associated with 24 rare diseases, and compared them to 24 chronic ailments like diabetes, heart disease, arthritis and cancers.
Let's personalize your content